More specialist approaches include Sally Smith Hughes, "Making Dollars out of DNA: The First Major Patent in Biotechnology and Commercialization of Molecular Biology, 1974-1980," Isis vol. 92, no. 3 (Sept. 2001): 541-75; Jeannette Colyvas et. al. "How Do University Inventions Get Into Practice?" Management Sciences vol. 48, no. 1 (Jan. 2002): 61–72; Ashely J. Stevens, "The Enactment of Bayh–Dole," Journal of Technology Transfer vol. 29 (2004): 93–99; Richard R. Nelson, "The Market Economy, and the Scientific Commons," Research Policy 33 (2004) 455–471; Shobita Parthasarathy, "The Patent Is Political: The Consequences of Patenting the BRCA Genes in Britain," Community Genetics vol. 8 (2005): 235-242; John P. Walsh et. al. "View from the Bench: Patents and Material Transfers," Science vol. 309 (23 Sept 2005): 2002-3; Aaron S. Kesselheim and Jerry Avorn, "University-Based Science and Biotechnology Products Defining the Boundaries of Intellectual Property," JAMA vol. 293, no. 7 (Feb. 16, 2005): 850-54; Kyle Jensen and Fiona Murray, "Intellectual Property Landscape of the Human Genome," Science, vol. 310, no. 14 (Oct. 2005): 239-40; Barbara Caulfield et. al. "Evidence and Anecdotes: An Analysis of Human Gene Patenting Controversies," Nature Biotechnology 24:9 (Sept. 2006): 1091-94; Anon., "Best Practices for the Licensing of Genomic Inventions," Federal Register vol. 69, no. 223 (Nov. 19, 2004): 67747-48.